nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in advanced non-small cell lung cancer
|
Salifu, Idoko |
|
|
36 |
C |
p. |
artikel |
2 |
Assessing knowledge, attitude and practice towards prostate cancer screening among males in Southwest Tanzania: A cross-sectional study
|
Makungu, Mariam L. |
|
|
36 |
C |
p. |
artikel |
3 |
Assessing Syrian women's knowledge of breast cancer risk factors, warning signs, and barriers to preventive measures: A cross-sectional study
|
Bohsas, Haidara |
|
|
36 |
C |
p. |
artikel |
4 |
A study on antimicrobial and anticancer properties of Cissus quadrangulris using lung cancer cell line
|
Payani, Sholapuri |
|
|
36 |
C |
p. |
artikel |
5 |
Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer
|
Bender, L. |
|
|
36 |
C |
p. |
artikel |
6 |
Clinical outcomes of stage-IV non–small-cell lung cancer in young patients and the impact of tumor markers
|
dos Santos, Pedro Augusto Reck |
|
|
36 |
C |
p. |
artikel |
7 |
Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea
|
Ahn, Beung-Chul |
|
|
36 |
C |
p. |
artikel |
8 |
Comparison of sequential versus simultaneous integrated boost of volumetric modulated arc therapy in treatment of oropharyngeal carcinoma
|
Kachhwaha, Avni |
|
|
36 |
C |
p. |
artikel |
9 |
3-deazaadenosine: A promising novel p38γ antagonist with potential as a breast cancer therapeutic agent
|
Natarajan, Pradeep |
|
|
36 |
C |
p. |
artikel |
10 |
Effectiveness of natural-based products for radiation-induced oral mucositis therapy: A systematic review
|
Pranadwista, Zulfa Fidi |
|
|
36 |
C |
p. |
artikel |
11 |
Efficient drug delivery to lymph nodes by intradermal administration and enhancement of anti-tumor effects of immune checkpoint inhibitors
|
Tanaka, Ryo |
|
|
36 |
C |
p. |
artikel |
12 |
Erratum to A comparison of cancer vaccine adjuvants in clinical trials [Cancer Treatment and Research Communications Volume 34, 2023, 100667]
|
Morgan, Marriott |
|
|
36 |
C |
p. |
artikel |
13 |
Erratum to Multi-modality management of chondrosarcoma of scapula: A case report and review of literature [Cancer Treatment and Research Communications Volume 35, 2023, 100710]
|
Ramakant, Tiwari |
|
|
36 |
C |
p. |
artikel |
14 |
Expression of Anaplastic Lymphoma Kinase (ALK) in glioma and possible clinical correlations. A retrospective institutional study
|
Azab, Mohammed A. |
|
|
36 |
C |
p. |
artikel |
15 |
High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiology
|
Voutsadakis, Ioannis A. |
|
|
36 |
C |
p. |
artikel |
16 |
HPV testing for cervical cancer screening: Should reflex cytology be performed after a positive test for HPV 16 and 18?
|
Caeiro, Vitor |
|
|
36 |
C |
p. |
artikel |
17 |
Insilco prediction of the role of the FriZZled5 gene in colorectal cancer
|
Hosseini-Abgir, Alireza |
|
|
36 |
C |
p. |
artikel |
18 |
Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspects
|
Fernandes, Gabriela |
|
|
36 |
C |
p. |
artikel |
19 |
Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor
|
Leerhoff, Sabine |
|
|
36 |
C |
p. |
artikel |
20 |
Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer
|
Matsumoto, Saya |
|
|
36 |
C |
p. |
artikel |
21 |
Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer
|
Gupta, Anshul |
|
|
36 |
C |
p. |
artikel |
22 |
Non-coding RNAs, cancer treatment and cardiotoxicity: A triad of new hope
|
Mittal, Rishabh |
|
|
36 |
C |
p. |
artikel |
23 |
Patient profiles, treatment patterns, and outcomes among persistent, recurrent, or metastatic cervical cancer patients under routine care in the United States
|
Gokhale, Mugdha |
|
|
36 |
C |
p. |
artikel |
24 |
Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study
|
Chen, Jida |
|
|
36 |
C |
p. |
artikel |
25 |
Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysis
|
Awad, Ahmed K. |
|
|
36 |
C |
p. |
artikel |
26 |
Pharmaceutical industry funding and chemotherapy trials for prostate cancer: A systematic review
|
Heydari, Amirreza |
|
|
36 |
C |
p. |
artikel |
27 |
Predictive factors for nodal recurrence in differentiated thyroid cancers
|
Kaur, Japneet |
|
|
36 |
C |
p. |
artikel |
28 |
Primary colorectal diffuse large B-cell lymphoma: A report of eighteen cases in a tertiary care center
|
Vasconcelos, Flavia da Cunha |
|
|
36 |
C |
p. |
artikel |
29 |
Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer
|
MacDonald, Madeline |
|
|
36 |
C |
p. |
artikel |
30 |
Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational study
|
Shah, Anne |
|
|
36 |
C |
p. |
artikel |
31 |
Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer
|
Amonkar, Mayur M. |
|
|
36 |
C |
p. |
artikel |
32 |
Right colon cancer: The influence of specific location on recurrence and survival
|
Cavadas, Ana Sofia |
|
|
36 |
C |
p. |
artikel |
33 |
Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center
|
Thibodeau, Stephane |
|
|
36 |
C |
p. |
artikel |
34 |
Synchronous endometrial and ovarian cancer and its recurrent risk factors: Case series
|
Hoorshad, Niloufar |
|
|
36 |
C |
p. |
artikel |
35 |
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report
|
Desai, Aakash |
|
|
36 |
C |
p. |
artikel |
36 |
Treatment of unresectable stage III NSCLC: Real world cohort study and literature review
|
Verfaillie, Saartje |
|
|
36 |
C |
p. |
artikel |
37 |
Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer
|
Carroll, Nikki M. |
|
|
36 |
C |
p. |
artikel |